LASSBio-1829 HCl is an orally bioavailable IKK2 inhibitor. References: Guedes IA, Freitas RH, Cordeiro NM, do Nascimento TS, Valerio TS, Fernandes PD, Dardenne LE, Fraga CA. LASSBio-1829 Hydrochloride: Development of a New Orally Active N-Acylhydrazone IKK2 Inhibitor with Anti-inflammatory Properties. ChemMedChem. 2016 Jan 19;11(2):234-44. doi: 10.1002/cmdc.201500266. Epub 2015 Aug 25. PubMed PMID: 26306006.

纯度：≥98%

CAS：1807810-16-7